For the year ending 2025-12-31, ALGN had $51,223K increase in cash & cash equivalents over the period. $490,778K in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income | 410,351 | 421,362 | 445,053 | 361,573 |
| Deferred taxes | 33,085 | 25,756 | -18,642 | -39,495 |
| Depreciation and amortization | 237,436 | 145,034 | 142,401 | 125,793 |
| Stock-based compensation | 185,870 | 173,703 | 154,026 | 133,367 |
| Non-cash operating lease cost | 39,742 | 38,438 | 33,107 | 30,520 |
| Impairments on equity investments | - | - | 4,990 | - |
| Impairment loss on assets held for sale | 23,142 | - | - | - |
| Arbitration award gain | - | - | 0 | 0 |
| Impairment and fair value adjustments for equity investments | -18,074 | -5,885 | - | - |
| Other non-cash operating activities | -37,686 | -12,256 | -32,733 | -41,288 |
| Accounts receivable | 139,909 | 153,487 | 104,614 | -21,549 |
| Inventories | -808 | -25,053 | -30,169 | 130,097 |
| Prepaid expenses and other assets | -13,431 | -67,527 | 51,013 | 65,514 |
| Accounts payable | 5,330 | -843 | -7,703 | -36,523 |
| Accrued and other long-term liabilities | -95,654 | 89,705 | 46,327 | -121,942 |
| Long-term income tax payable | -28,265 | -20,279 | -7,772 | 6,327 |
| Deferred revenues | -111,756 | -80,109 | 86,714 | 241,886 |
| Net cash provided by operating activities | 593,223 | 738,231 | 785,776 | 568,732 |
| Acquisitions, net of cash acquired | 0 | 77,075 | 0 | 12,304 |
| Purchase of property, plant and equipment | 102,445 | 115,580 | 177,716 | 291,900 |
| Purchase of marketable securities | 0 | 0 | 2,910 | 28,002 |
| Proceeds from maturities of marketable securities | 0 | 25,660 | 55,170 | 23,785 |
| Proceeds from sales of marketable securities | 0 | 18,193 | 6,234 | 97,316 |
| Repayment on unsecured promissory note | - | - | 0 | 0 |
| Proceeds from arbitration award | - | - | 0 | 0 |
| Purchase of equity investments | 10,000 | 106,345 | 76,999 | - |
| Other investing activities | 0 | -235 | -278 | 2,211 |
| Net cash used in investing activities | -112,445 | -254,912 | -195,943 | -213,316 |
| Proceeds from issuance of common stock | 21,749 | 25,281 | 26,595 | 26,149 |
| Common stock repurchases, net of excise tax | 465,939 | 352,878 | 592,360 | 435,036 |
| Payment for equity forward contract related to accelerated stock repurchase agreement | - | - | - | 40,000 |
| Activity for equity forward contracts related to accelerated stock repurchase agreements, net | 0 | 0 | 10,000 | - |
| Payroll taxes paid upon the vesting of equity awards | 20,390 | 28,125 | 22,575 | 52,799 |
| Net cash used in financing activities | -464,580 | -355,722 | -598,340 | -501,686 |
| Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash | 35,025 | -21,153 | 4,671 | -11,514 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | 51,223 | 106,444 | -3,836 | -157,784 |
| Cash, cash equivalents, and restricted cash at beginning of year | 1,044,963 | 938,519 | 942,355 | 1,100,139 |
| Cash, cash equivalents, and restricted cash at end of year | 1,096,186 | 1,044,963 | 938,519 | 942,355 |
ALIGN TECHNOLOGY INC (ALGN)
ALIGN TECHNOLOGY INC (ALGN)